126 related articles for article (PubMed ID: 34046730)
1. A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [
Kolinger GD; Vállez García D; Lohith TG; Hostetler ED; Sur C; Struyk A; Boellaard R; Koole M
EJNMMI Res; 2021 May; 11(1):49. PubMed ID: 34046730
[TBL] [Abstract][Full Text] [Related]
2. Comparison between a dual-time-window protocol and other simplified protocols for dynamic total-body
Wang Z; Wu Y; Li X; Bai Y; Chen H; Ding J; Shen C; Hu Z; Liang D; Liu X; Zheng H; Yang Y; Zhou Y; Wang M; Sun T
EJNMMI Phys; 2022 Sep; 9(1):63. PubMed ID: 36104580
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
[TBL] [Abstract][Full Text] [Related]
4. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
[No Abstract] [Full Text] [Related]
5. In vivo quantification of neurofibrillary tangles with [
Pascoal TA; Shin M; Kang MS; Chamoun M; Chartrand D; Mathotaarachchi S; Bennacef I; Therriault J; Ng KP; Hopewell R; Bouhachi R; Hsiao HH; Benedet AL; Soucy JP; Massarweh G; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2018 Jul; 10(1):74. PubMed ID: 30064520
[TBL] [Abstract][Full Text] [Related]
6. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry and efficacy of a tau PET tracer [
Ohnishi A; Akamatsu G; Ikari Y; Nishida H; Shimizu K; Matsumoto K; Aita K; Sasaki M; Yamamoto Y; Yamane T; Senda M
Ann Nucl Med; 2023 Feb; 37(2):108-120. PubMed ID: 36411357
[TBL] [Abstract][Full Text] [Related]
8. Spatially constrained kinetic modeling with dual reference tissues improves
Zhou Y; Flores S; Mansor S; Hornbeck RC; Tu Z; Perlmutter JS; Ances B; Morris JC; Gropler RJ; Benzinger TLS
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3172-3186. PubMed ID: 33599811
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Evaluation of the Tau PET Radiotracer
Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
[No Abstract] [Full Text] [Related]
10. Optimized dual-time-window protocols for quantitative [
Heeman F; Yaqub M; Lopes Alves I; Heurling K; Berkhof J; Gispert JD; Bullich S; Foley C; Lammertsma AA;
EJNMMI Res; 2019 Mar; 9(1):32. PubMed ID: 30919133
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Tau Load Using [
Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M
Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171
[TBL] [Abstract][Full Text] [Related]
12. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
[TBL] [Abstract][Full Text] [Related]
13. Validation of Noninvasive Tracer Kinetic Analysis of
Bullich S; Barthel H; Koglin N; Becker GA; De Santi S; Jovalekic A; Stephens AW; Sabri O
J Nucl Med; 2018 Jul; 59(7):1104-1110. PubMed ID: 29175981
[TBL] [Abstract][Full Text] [Related]
14. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.
Wong KP; Kepe V; Dahlbom M; Satyamurthy N; Small GW; Barrio JR; Huang SC
Neuroimage; 2012 Mar; 60(1):241-51. PubMed ID: 22197787
[TBL] [Abstract][Full Text] [Related]
16. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
17. [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.
Tantawy MN; Jones CK; Baldwin RM; Ansari MS; Conn PJ; Kessler RM; Peterson TE
Nucl Med Biol; 2009 Nov; 36(8):931-40. PubMed ID: 19875049
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of [
Schmidt ME; Janssens L; Moechars D; Rombouts FJR; Timmers M; Barret O; Constantinescu CC; Madonia J; Russell DS; Sandiego CM; Kolb H
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3176-3185. PubMed ID: 32535652
[TBL] [Abstract][Full Text] [Related]
19. Test-retest characteristic of [
Salinas C; Lohith TG; Purohit A; Struyk A; Sur C; Bennacef I; Beaver J; Martarello L
J Cereb Blood Flow Metab; 2020 Nov; 40(11):2179-2187. PubMed ID: 31711342
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Comparison of Tau Radioligands
Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
